The bill requires the division of criminal justice to provide human trafficking training to law enforcement agencies and entities that provide services to human trafficking victims. The training may include: Train-the-trainer programs; Direct trainings; and Online training programs. The training may be provided to law enforcement agencies, organizations that provide direct services to human trafficking victims, school personnel and parents or guardians of students, and any other organization, agency, or group that would benefit from such training. The training must be developed in consultation with the Colorado human trafficking council. When considering requests for training, the division should give priority to requests from areas of the state that have limited access to training resources. Beginning in 2019, the council's annual human trafficking report must include an update on the training provided. The bill requires the school safety resource center to include awareness and prevention of human trafficking in the materials and training that it provides. The bill appropriates $69,922 and 0.8 FTE to the division of criminal justice in the department of public safety from the general fund to implement the bill. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) Read More
Sponsored bills
The bill enacts the 'Colorado Prescription Drug Price Transparency Act of 2018', which requires: Health insurers, starting in 2021, to submit to the commissioner of insurance (commissioner), as part of the health care cost reporting requirement, information regarding prescription drugs covered under their health insurance plans that were dispensed in the preceding calendar year; Prescription drug manufacturers to notify state purchasers, health insurers, and pharmacy benefit management firms when the manufacturer, on or after July 1, 2020, increases the price of certain prescription drugs by more than 10% or introduces a new specialty drug in the commercial market; and Prescription drug manufacturers, within 15 days after the end of each calendar quarter that starts on or after July 1, 2020, to provide specified information to the commissioner regarding the drugs about which manufacturers are required to notify purchasers of a drug price increase or new specialty drug on the market. The commissioner is required to post the information received from prescription drug manufacturers on the division of insurance website. Additionally, the commissioner, or a disinterested third-party contractor, is to analyze the data submitted by health insurers and prescription drug manufacturers and other relevant information to determine the effect of prescription drug costs on health insurance premiums. The commissioner is to publish a report each year, submit the report to specified legislative committees, and present the report during annual 'State Measurement for Accountable, Responsive, and Transparent (SMART) Government Act' hearings. The commissioner is authorized to adopt rules as necessary to implement the requirements of the act. A prescription drug manufacturer that fails to notify purchasers or fails to report required data to the commissioner is subject to discipline by the state board of pharmacy, including a penalty of $1,000 per day for each day the manufacturer fails to comply with the notice or reporting requirements. The commissioner is to report manufacturer violations to the state board of pharmacy. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) Read More
Sunset Process - House Health, Insurance, and Environment Committee. Sections 1 and 2 of the bill continue the regulation of people who modify the weather until 2033. Section 3 repeals a provision that prohibits weather modification that benefits another state if the other state prohibits weather modification that benefits Colorado.(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) , Read More
The bill enacts the 'Genetic Counselor Licensure Act'. On and after June 1, 2019, a person cannot practice genetic counseling without being licensed by the director of the division of professions and occupations in the department of regulatory agencies. To be licensed, a person must have graduated with an appropriate genetic counseling degree and have been certified by a national body, except that the director may issue a provisional license to a candidate for certification pursuant to requirements established by rule. The bill gives title protection to genetic counselors and standard licensing, rule-making, and disciplinary powers to the director. Genetic counselors must have insurance unless the director, by rule, finds that insurance is not reasonably available. The bill repeals the act on September 1, 2025. Genetic counselors are subject to the mandatory disclosures of the 'Michael Skolnik Medical Transparency Act of 2010'. $22,677 is appropriated to the department of regulatory agencies from the division of professions and occupations cash fund to implement the act. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) , Read More
The bill recreates the former health care task force, renamed as the statewide health care review committee, to study health care issues that affect Colorado residents throughout the state. The committee consists of the members of the house of representatives committees on health, insurance, and environment and on public health care and human services and the senate committee on health and human services. The committee is permitted to meet up to 2 times during the interim between legislative sessions, including 2 field trips. For the 2018-19 fiscal year, the bill appropriates $23,951 from the general fund to the legislative department to implement the bill. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) , Read More
Not more than 30 days after receiving at least $750,000 in gifts, grants, and donations for the purpose of creating and administering a statewide electronic system (system) that allows medical professionals and individuals to upload and access advance directives, the department of public health and environment shall create such a system. 'Advance directive' means: A declaration as to medical treatment; A medical durable power of attorney; A directive relating to cardiopulmonary resuscitation; A medical orders for scope of treatment form; A designated beneficiary agreement; or Any legal form of these types that has been properly executed in another state in accordance with the laws of that state. The department shall contract with one or more health information organization networks for the administration and maintenance of the system during the next year. On or before November 1, 2018, the department shall promulgate rules to administer the system. The system is repealed, effective September 1, 2028. Prior to such repeal, the department of regulatory agencies shall perform a sunset review of the system. (Note: This summary applies to this bill as introduced.) Read More
The bill updates statutory references to Alzheimer's and other dementia diseases and reflects that dementia diseases have related disabilities impacting memory and other cognitive abilities. Missing persons with a dementia disease and related disability are added to the missing senior citizen and missing person with developmental disabilities alert program, and the program is renamed to reflect this change. The Alzheimer's disease treatment and research center within the university of Colorado school of medicine is renamed the dementia diseases and related disabilities treatment and research center. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) , Read More
Current law requires a naturopathic doctor to use the term "registered" in the doctor's title. The bill changes the titles that naturopathic doctors may use by eliminating the word "registered". (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) , Read More
The bill allows a pharmaceutical manufacturer or its representative to promote the off-label use of a prescription drug, biological product, or device approved by the United States food and drug administration. (Note: This summary applies to this bill as introduced.) , Read More
House Bill 16-1324 allowed a veterinarian to maintain an office stock of compounded drugs, which are drugs that are combined, mixed, or otherwise altered to create a specific drug or formulation, for later distribution or administration to animal patients. The bill defines 'food animal' and sets forth the limited circumstances under which a veterinarian may administer or dispense a compounded drug obtained from a prescription drug outlet for a food animal. The bill further clarifies that references to 'patient' set forth in House Bill 16-1324 refer to an 'animal patient'. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)